An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
NCT03290781
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
366
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
Ontamalimab
OTHER:
Placebo
Sponsor
Shire